← Back to Search

Other

Amniotic Fluid (AFED) for Photorefractive Keratectomy

Phase 1 & 2
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative months 1, 3, 6, and 12
Awards & highlights

Study Summary

This trial is testing if a new eye drop is safe for people who have a type of eye surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative months 1, 3, 6, and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative months 1, 3, 6, and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety - Adverse Events Including Serious Adverse Events
Secondary outcome measures
Corneal Staining in Each Eye
Corneal Surface Regularity
Count of Participants Who Reported Oral Pain Medication Usage
+3 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Amniotic Fluid (AFED)Active Control1 Intervention
Group II: Saline SolutionPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,628 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available slots within this research project for participants?

"As per the details posted on clinicaltrials.gov, this specific medical trial is no longer seeking participants; its first posting was on July 10th 2020 and its last update occurred on February 7th 2022. However, two other trials are enrolling patients currently."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)
Mark Mifflin 2020. "Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04281004.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top